8-K ·Filed Aug 17, 2026

LH

LABCORP HOLDINGS INC.
NEUTRAL
Impact 2/10
Horizonweeks Processed1mo ago SEC0000920148-26-000185
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

No immediate trading signal. Traders should watch the September 10 Investor Day for any material updates on strategy, capital allocation, or long-term financial targets. The event may introduce new guidance or strategic pivots.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d
LH ▲ +0.19% at T+20d
NEUTRAL call ✓ call won +0.19% · α vs SPY +2.17% · entry $323.34 → $323.97
Next anchor: T+60d in 6w
Latest observation: T+32 -17.20% FF3 residual α
Entry anchored
Aug 17, 04:00 AM ET
via 1-min bar
T+1d
-0.36%
call -0.36% · α +0.32%
$322.18
settled 6w ago
T+5d
+4.95%
call +4.95% · α +6.14%
$339.34
settled 6w ago
T+20d
+0.19%
call +0.19% · α +2.17%
$323.97
settled 17d ago
T+60d
—
call — · α —
—
in 6w

Price Chart

Loading chart...

Executive Summary

Labcorp announced it will host an Investor Day on September 10, 2026, where management will discuss strategy, capital deployment priorities, and long-term financial outlook. This is a routine scheduling announcement with no financial results or guidance released. No material new information was disclosed.

Key Facts

  • Investor Day scheduled for September 10, 2026, from 9 a.m. to noon ET.
  • Presenters include CEO Adam Schechter, CFO Julia Wang, and other executive leaders.
  • Topics: go-forward strategy, capital deployment priorities, and long-term financial outlook.
  • Webcast available via Labcorp Investor Relations site with replay after the event.

Financial Impact

No financial figures were disclosed in this filing.

Risk Factors

  • Risk that Investor Day presentations lack material new information, leading to no price reaction.
  • Potential for unfavorable long-term outlook if guidance or capital deployment plans disappoint.

Market Snapshot

Exchange
NYSE
Sector
Services-Medical Laboratories
Analyst Consensus
78% bullish (27 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000920148-26-000185
Document: formpr081726ex991investord.htm0000920148-26-000185
Document: 0000920148-26-000185-index-headers.html0000920148-26-000185
Document: 0000920148-26-000185-index.html0000920148-26-000185
Document: 0000920148-26-000185.txt0000920148-26-000185
15 reports for LH
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +17.60%Apr 30, 2026
Filters
Rows
Reports for LH — sortable, filterable
TypeNow
Sep 10, 2026
22d ago
8-K
NEUTRAL ★ 5/10
$311.54 $320.71▲ +2.94%▲ +3.16%$308.49 (−0.98%)
Aug 28, 2026
5w ago
8-K
NEUTRAL ★ 2/10
$335.11 $326.89▼ −2.45%▼ −2.56%$308.49 (−7.94%)
Aug 18, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$322.18 $337.68▲ +4.81%▲ +5.01%$308.49 (−4.25%)
Aug 17, 2026
6w ago
8-K
NEUTRAL ★ 2/10
$323.34 $339.34▲ +4.95%▲ +6.14%$308.49 (−4.59%)
Aug 14, 2026
7w ago
8-K
NEUTRAL ★ 2/10
$318.13 $336.34▲ +5.72%▲ +7.09%$308.49 (−3.03%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$323.48 $330.44▲ +2.15%▲ +2.60%$308.49 (−4.63%)
Aug 6, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$316.53 $322.59▲ +1.91%▲ +0.70%$308.49 (−2.54%)
Jul 30, 2026
9w ago
8-K
BULLISH ★ 7/10
$315.53 $316.53▲ +0.32%▼ −3.31%$308.49 (−2.23%)
Jul 10, 2026
12w ago
8-K
NEUTRAL ★ 2/10
$276.81 $281.94▲ +1.85%▲ +2.41%$308.49 (+11.44%)
Jun 30, 2026
13w ago
8-K
NEUTRAL ★ 2/10
$283.88 $283.86▼ −0.01%▼ −0.27%$308.49 (+8.67%)
Showing 10 of 15

US Market Status

Market Closed — Opens Mon (64h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access